University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital
Search Site | Find a Doctor
Print this page
FONT SIZE
Home > Doctors > Marshall L. Stoller

Marshall L. Stoller, M.D.

Urologist

Dr. Marshall L. Stoller is medical director of the Urinary Stone Center at UCSF Medical Center that provides care for urinary stone disease including minimally invasive techniques or techniques requiring only small incisions such as endourology and laparoscopy. Stoller has helped spearhead a comprehensive program in the management of urinary stone disease, utilizing and testing a variety of lithotriptors, a non-invasive device that pulverizes urinary stones. Stoller is certified by the American Board of Urology. He has received many awards, including grand prize in the annual Lapides Essay Contest in Urodynamic and Neurourology Research.

Stoller graduated from the University of California at Berkeley in 1976 and went to medical school at Baylor College of Medicine in Houston, Texas. After medical school, he returned to the Bay Area, where he was a general surgical intern and resident and a urology resident at the University of California, San Francisco from 1981 to 1985. The following year, he became a clinical instructor and research fellow at the University of New South Wales at Prince Henry and Prince of Wales Hospitals in Sydney, Australia. Stoller returned to UCSF as chief resident in urology and then joined the medical staff. He is a professor in residence in urology and has received the Distinction in Teaching Award from the Academic Senate at UCSF.

Clinics

Urology Practice
400 Parnassus Ave., Sixth Floor, Suite A610
San Francisco, CA 94143
Phone: (415) 353-2200
Fax: (415) 353-2641

Hours: Monday to Friday
8 a.m. – 5 p.m.

More about Marshall L. Stoller

Education

Baylor College of Medicine 1981

Residencies

UCSF Medical Center, Urology 1987

Selected Research and Publications

  1. Sur RL, Masterson JH, Palazzi KL, L'esperance JO, Auge BK, Chang DC, Stoller ML. Impact of statins on nephrolithiasis in hyperlipidemic patients: a 10-year review of an equal access health care system. Clin Nephrol. 2013 May; 79(5):351-5.
  2. Miller J, Durack JC, Sorensen MD, Wang JH, Stoller ML. Renal calyceal anatomy characterization with 3-dimensional in vivo computerized tomography imaging. J Urol. 2013 Feb; 189(2):562-7.
  3. Blaschko SD, Chi T, Miller J, Flechner L, Fakra S, Kapahi P, Kahn A, Stoller ML. Strontium substitution for calcium in lithogenesis. J Urol. 2013 Feb; 189(2):735-9.
  4. Bagga HS, Chi T, Miller J, Stoller ML. New insights into the pathogenesis of renal calculi. Urol Clin North Am. 2013 Feb; 40(1):1-12.
  5. Blaschko SD, Miller J, Chi T, Flechner L, Fakra S, Kahn A, Kapahi P, Stoller ML. Microcomposition of human urinary calculi using advanced imaging techniques. J Urol. 2013 Feb; 189(2):726-34.
  6. Wu AK, Tran TC, Sorensen MD, Durack JC, Stoller ML. Relative renal function does not improve after relieving chronic renal obstruction. BJU Int. 2012 May; 109(10):1540-4.
  7. Sorensen MD, Duh QY, Grogan RH, Tran TC, Stoller ML. Urinary parameters as predictors of primary hyperparathyroidism in patients with nephrolithiasis. J Urol. 2012 Feb; 187(2):516-21.
  8. Sorensen MD, Duh QY, Grogan RH, Tran TC, Stoller ML. Differences in metabolic urinary abnormalities in stone forming and nonstone forming patients with primary hyperparathyroidism. Surgery. 2012 Mar; 151(3):477-83.
  9. Chi T, Stoller ML. Stones: Passing a stone in your sleep might be easier than you think. Nat Rev Urol. 2011 Oct; 8(10):533-4.
  10. Sumorok NT, Asplin JR, Eisner BH, Stoller ML, Goldfarb DS. Effect of diet orange soda on urinary lithogenicity. Urol Res. 2012 Jun; 40(3):237-41.
  11. Villalta JD, Sorensen MD, Durack JC, Kerlan RK, Stoller ML. Selective arterial embolization of angiomyolipomas: a comparison of smaller and larger embolic agents. J Urol. 2011 Sep; 186(3):921-7.
  12. Breyer BN, Sen S, Aaronson DS, Stoller ML, Erickson BA, Eisenberg ML. Use of Google Insights for Search to track seasonal and geographic kidney stone incidence in the United States. Urology. 2011 Aug; 78(2):267-71.
  13. Reiner AP, Kahn A, Eisner BH, Pletcher MJ, Sadetsky N, Williams OD, Polak JF, Jacobs DR, Stoller ML. Kidney stones and subclinical atherosclerosis in young adults: the CARDIA study. J Urol. 2011 Mar; 185(3):920-5.
  14. Le JD, Eisner BH, Tseng TY, Chi T, Stoller ML. Laterality of nephrocalcinosis in kidney stone formers with severe hypocitraturia. BJU Int. 2011 Jan; 107(1):106-10.
  15. Tseng TY, Stoller ML. Medical and medical/urologic approaches in acute and chronic urologic stone disease. Med Clin North Am. 2011 Jan; 95(1):169-77.
  16. Eisner BH, Zargooshi J, Berger AD, Cooperberg MR, Doyle SM, Sheth S, Stoller ML. Gender differences in subcutaneous and perirenal fat distribution. Surg Radiol Anat. 2010 Nov; 32(9):879-82.
  17. Castle SM, Cooperberg MR, Sadetsky N, Eisner BH, Stoller ML. Adequacy of a single 24-hour urine collection for metabolic evaluation of recurrent nephrolithiasis. J Urol. 2010 Aug; 184(2):579-83.
  18. Eisner BH, Eisenberg ML, Stoller ML. Relationship between body mass index and quantitative 24-hour urine chemistries in patients with nephrolithiasis. Urology. 2010 Jun; 75(6):1289-93.
  19. Eisner BH, Asplin JR, Goldfarb DS, Ahmad A, Stoller ML. Citrate, malate and alkali content in commonly consumed diet sodas: implications for nephrolithiasis treatment. J Urol. 2010 Jun; 183(6):2419-23.
  20. Eisner BH, Porten SP, Bechis SK, Stoller ML. Diabetic kidney stone formers excrete more oxalate and have lower urine pH than nondiabetic stone formers. J Urol. 2010 Jun; 183(6):2244-8.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions by logging on to UCSF Profiles.

Home • Terms of Use • Site Map • Contact Us       © 2002 - 2013 The Regents of The University of California